EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D

Enrique Soto-Pedre iD, Yeun Yi Lin, Jimena Soto-Hernaez, Paul J Newey, Graham P Leese

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Enrique Soto-Pedre und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Health & Genomics, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Osteoporosis, Diabetes Mellitus, Cerebrovascular Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHS Tayside Research Endowments.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Primary hyperparathyroidism (PHPT) is associated with increased risk of morbidity and death, and vitamin D levels are a potentially confounding variable.

Objective

The aim of this study was to assess morbidity and mortality associated with primary hyperparathyroidism (PHPT).

Methods

In this population-based retrospective matched cohort study, data linkage of biochemistry, hospital admissions, prescribing, imaging, pathology, and deaths was used to identify patients across the region of Tayside, Scotland, who had PHPT from 1997 to 2019. Cox proportional hazards models and hazards ratios (HR) were used to explore the relationship between exposure to PHPT and several clinical outcomes. Comparisons were made with an age- and gender-matched cohort.

Results

In 11 616 people with PHPT (66.8% female), with a mean follow-up period of 8.8 years, there was an adjusted HR of death of 2.05 (95% CI, 1.97-2.13) for those exposed to PHPT. There was also an increased risk of cardiovascular disease (HR = 1.34; 95% CI, 1.24-1.45), cerebrovascular disease (HR = 1.29; 95% CI, 1.15-1.45), diabetes (HR = 1.39; 95% CI, 1.26-1.54), renal stones (HR = 3.02; 95% CI, 2.19-4.17) and osteoporosis (HR = 1.31; 95% CI, 1.16-1.49). Following adjustment for serum vitamin D concentrations (n = 2748), increased risks for death, diabetes, renal stones, and osteoporosis persisted, but not for cardiovascular or cerebrovascular disease.

Conclusion

In a large population-based study, PHPT was associated with death, diabetes, renal stones, and osteoporosis, independent of serum vitamin D concentration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryOsteoporosisDiabetes MellitusCerebrovascular DisordersHumansFemaleMaleVitamin DRetrospective StudiesCohort StudiesMorbidityVitaminsCalciumParathyroid Hormone

Stichwörter der Autor:innen

calciummortalityprimary hyperparathyroidismvitamin D

Substanzen

Vitamin DVitaminsCalciumParathyroid Hormone

Autor:innen und Institutionen

  • Division of Population Health & Genomics, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.
  • Department of Endocrinology and Diabetes, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.
  • School of Medicine, University of Bristol, Bristol BS8 1QU, UK.
  • Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK.

ORCID-Profile: Enrique Soto-Pedre

Förderung

  • NHS Tayside Research Endowments

Zitieren

APA

Soto-Pedre, E., Lin, Y. Y., Soto-Hernaez, J., Newey, P. J., & Leese, G. P. (2023). Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad103

Vancouver

Soto-Pedre E, Lin YY, Soto-Hernaez J, Newey PJ, Leese GP. Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad103

BibTeX
@article{SotoPedre2023,
  author = {Soto-Pedre, Enrique and Lin, Yeun Yi and Soto-Hernaez, Jimena and Newey, Paul J and Leese, Graham P},
  title = {Morbidity Associated With Primary Hyperparathyroidism—A Population-based Study With a Subanalysis on Vitamin D},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad103}
}
Kostenlos starten →